Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

An update on Becker muscular dystrophy.

Current opinion in neurology - 1 Oct 2023

Straub Volker, Guglieri Michela

Abstract excerpt

PURPOSE OF REVIEW: The purpose of this review is to summarise the recent developments in trial readiness, natural history studies, and interventional clinical trials for Becker muscular dystrophy (BMD). RECENT FINDINGS: As several treatment concepts have claimed to convert patients with Duchenne muscular dystrophy (DMD) into a BMD phenotype, BMD itself has moved into the focus of clinical research. Natural...

Topics

Humans
Muscular Dystrophy, Duchenne
Phenotype
Research Design

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37591308
DOI: 10.1097/WCO.0000000000001191
PMCID: PMC10487383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An update on Becker muscular dystrophy.PMID 37591308Read ↗

Current and emerging therapies in Becker muscular dystrophy (BMD).Semantic proximity Read ↗

Findings from the Longitudinal CINRG Becker Natural History Study.Semantic proximity Read ↗

Diagnosis and management of Becker muscular dystrophy: the French guidelines.Semantic proximity Read ↗

The CINRG Becker Natural History Study: Baseline characteristics.Semantic proximity Read ↗

Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.Semantic proximity Read ↗

Muscular dystrophy: new challenges and review of the current clinical trials.Semantic proximity Read ↗

Drug development progress in duchenne muscular dystrophySemantic proximity Read ↗

Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophySemantic proximity Read ↗

Natural history of Becker muscular dystrophy: a multicenter study of 225 patients.Semantic proximity Read ↗

New and emerging pharmacotherapy for duchenne muscular dystrophy: a focus on synthetic therapeutics.Semantic proximity Read ↗

Towards a Cure: Emerging Therapeutic Advances for DMD, LGMD, and GNEM- Insights from Pre-Clinical and Clinical ResearchSemantic proximity Read ↗

Interventions for muscular dystrophy: molecular medicines entering the clinic.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.